CD4 and neoplasm: <i>BRCA1</i> mutations were associated with CD8<sup>+</sup> Trm expansion, whereas <i>BRCA2</i> mutations were linked to tumor CD4<sup>+</sup> Trm expansion and peripheral T/NK cell cytotoxicity.